| Date | Form | Description | Docs | XBRL | Pages |
| 10/24/19 | 8-K | Current report filing |
|
27 | |
| 09/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/12/19 | DEF 14A | Definitive proxy statements |
|
46 | |
| 09/06/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
84 |
Latest News & Events
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds
Read More...Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline
Read More...Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
Read More...